Brenus Pharma Announces First Patients Dosed in its First-in-Human Trial Evaluating STC-1010, a Next-Generation Immunotherapy
Brenus and InSphero Recreate Human Colorectal Cancer in 3D to Validate STC-1010’s Therapeutic Efficacy”
Brenus is proud to be part of the French Delegation at BIOUS 2025 Let’s connect and share insights
AACR 2025: Brenus Pharma presents late-breaking preclinical data of STC-1010
The Times Magazine : Brenus Pharma Secures $25 Million to Propel Clinical Trials for Precision Cancer Vaccines
Read the article here
EU Startup – Lyon-based Brenus Pharma raises €22.2 million for precision cancer vaccines
Read the article
BMF Business (FR) French Tech : Vaccins, futur de la lutte contre le cancer ?
See Video here
Les Echos (FR) – Brenus Pharma réunit 22 millions pour lancer les essais cliniques de son vaccin anticancer
https://www.lesechos.fr/pme-regions/innovateurs/brenus-pharma-reunit-22-millions-pour-lancer-les-essais-cliniques-de-son-vaccin-anticancer-2119589
Paul Bravetti, was Laure Closier’s guest on French Tech, BFMTV,to discuss the fundraising to finance clinical trials
It’s a wrap San Diego! #BIO2024
It’s a wrap San Diego! 🇺🇸 We are leaving #BIO2024 after a lot of exciting encounters, discussions and conferences. The ecosystem is thriving with opportunities and BIO is for sure an inspiring moment to share among peers. Our very special thanks goes to Business France Healthcare – North America and Lyonbiopôle Auvergne-Rhône-Alpes for such a warm welcome, we always feel at home at the French Pavilion. See u soon